Empagliflozin to Prevent Post-Operative Atrial Fibrillation

PHASE3RecruitingINTERVENTIONAL
Enrollment

492

Participants

Timeline

Start Date

November 7, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Post-operative Atrial FibrillationCABG
Interventions
DRUG

Empagliflozin 10 MG

The intervention group will receive a 10 mg tablet of empagliflozin once a day from 3 days before surgery until discharge from the hospital.

DRUG

Placebo

The comparator group will receive a matching placebo from 3 days before surgery until discharge from the hospital.

Trial Locations (2)

1411713138

RECRUITING

Tehran Heart Center, Tehran

1995614331

RECRUITING

Rajaie Cardiovascular Medical & Research Center, Tehran

All Listed Sponsors
collaborator

Tehran Heart Center

OTHER

lead

Rajaie Cardiovascular Medical and Research Center

OTHER